HU0500145D0 - Composition for the treatment of oral diseases - Google Patents

Composition for the treatment of oral diseases

Info

Publication number
HU0500145D0
HU0500145D0 HU0500145A HUP0500145A HU0500145D0 HU 0500145 D0 HU0500145 D0 HU 0500145D0 HU 0500145 A HU0500145 A HU 0500145A HU P0500145 A HUP0500145 A HU P0500145A HU 0500145 D0 HU0500145 D0 HU 0500145D0
Authority
HU
Hungary
Prior art keywords
treatment
composition
oral diseases
oral
diseases
Prior art date
Application number
HU0500145A
Other languages
Hungarian (hu)
Original Assignee
Gene Res Lab N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gene Res Lab N filed Critical Gene Res Lab N
Priority to HU0500145A priority Critical patent/HUP0500145A2/en
Publication of HU0500145D0 publication Critical patent/HU0500145D0/en
Priority to PCT/IB2006/000147 priority patent/WO2006079910A2/en
Publication of HUP0500145A2 publication Critical patent/HUP0500145A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
HU0500145A 2005-01-28 2005-01-28 Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases HUP0500145A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0500145A HUP0500145A2 (en) 2005-01-28 2005-01-28 Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases
PCT/IB2006/000147 WO2006079910A2 (en) 2005-01-28 2006-01-20 0-(3-piperidino-2hydroxypropyl)nicotinic amixodime for treating lesions in the oral cavity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0500145A HUP0500145A2 (en) 2005-01-28 2005-01-28 Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases

Publications (2)

Publication Number Publication Date
HU0500145D0 true HU0500145D0 (en) 2005-04-28
HUP0500145A2 HUP0500145A2 (en) 2006-11-28

Family

ID=89985775

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0500145A HUP0500145A2 (en) 2005-01-28 2005-01-28 Use of o-(3-piperidino-2-hydroxy-1-propyl)-nicotinic amidoxime for preparation of medicaments against oral diseases

Country Status (2)

Country Link
HU (1) HUP0500145A2 (en)
WO (1) WO2006079910A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7763601B2 (en) 2006-11-02 2010-07-27 N-Gene Research Laboratories, Inc. Prevention and treatment of obesity
HUP1100444A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
HUP1100445A2 (en) 2011-08-17 2013-02-28 Pharma Gene Sa Pharmaceutical composition
SG11201405559TA (en) * 2012-03-09 2014-11-27 Inst Pasteur Shanghai Cas Component and method for treating viral disease
CN108541948A (en) * 2018-07-16 2018-09-18 怀化学院 A kind of lithocarpus litseifolius lozenge and preparation method thereof
HUP1800298A1 (en) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Combination of beta blocker and hydroximic acid derivative with reduced side effects

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HUT78139A (en) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Composition for reducing skin state aging

Also Published As

Publication number Publication date
WO2006079910A3 (en) 2006-10-05
WO2006079910A2 (en) 2006-08-03
HUP0500145A2 (en) 2006-11-28

Similar Documents

Publication Publication Date Title
IL195571A0 (en) Compounds for the treatment of periodontal disease
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
IL186578A0 (en) Compositions for treatment of neovascularization diseases
HK1131141A1 (en) Imidazolothiazole compounds for the treatment of disease
IL189622A0 (en) Pharmaceutical compositions for the treatment of inner ear disorders
IL208607A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
HK1166983A1 (en) Solid forms comprising compounds for the treatment of diseases or disorders, compositions thereof, and use therewith
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
EP1804787A4 (en) Flavonoid composition for treating oral diseases
ZA200900712B (en) Herbal compositions for the treatment of diseases of the oral cavity
EP2217238A4 (en) Methods and compositions for the treatment of proteinuric diseases
IL192415A0 (en) Pharmaceutical composition for the treatment of nail diseases
SI1890705T1 (en) Use of 24-nor-UDCA for the treatment of cholestatic liver diseases
HU0500145D0 (en) Composition for the treatment of oral diseases
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP1865952A4 (en) Histamine-containing composition for the treatment of allergic diseases
GB0400802D0 (en) Compounds for the treatment of disease
HUP0500685A2 (en) Pharmaceutical composition for the treatment of psychosis
ZA200606780B (en) Compounds for the treatment of diseases
HU0500947D0 (en) Composition for treatment of paradontosis
HUP0500948A2 (en) Composition for treatment of diabeticus paradontosis
ZA200708279B (en) Dermatological compositions and salts for the treatment of dermatological diseases
GB0420867D0 (en) Compounds for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees